AAAAAA
Results:
1-7
|
Results: 7
Authors:
Deporte-Fety, R
Picot, M
Amiand, M
Moreau, A
Campion, L
Lanoe, D
Renee, N
Milano, G
Citation: R. Deporte-fety et al., High-performance liquid chromatographic assay with ultraviolet detection for quantification of dihydrofluorouracil in human lymphocytes: application to measurement of dihydropyrimidine dehydrogenase activity, J CHROMAT B, 762(2), 2001, pp. 203-209
Authors:
Campone, M
Fumoleau, P
Delecroix, V
Deporte-Fety, R
Perrocheau, G
Vernillet, L
Borg-Olivier, O
Louboutin, JP
Bissery, MC
Riva, A
Azli, N
Citation: M. Campone et al., Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer, ANN ONCOL, 12(7), 2001, pp. 909-918
Authors:
Montazeri, A
Boucaud, M
Lokiec, F
Pinguet, F
Culine, S
Deporte-Fety, R
Albin, N
Laguerre, B
Goupil, A
Bugat, R
Canal, P
Chatelut, E
Citation: A. Montazeri et al., Population pharmacokinetics of topotecan: intraindividual variability in total drug, CANC CHEMOT, 46(5), 2000, pp. 375-381
Authors:
Douillard, JY
Bennouna, J
Vavasseur, F
Deporte-Fety, R
Thomare, P
Giacalone, F
Meflah, K
Citation: Jy. Douillard et al., Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer, CANCER IMMU, 49(1), 2000, pp. 56-61
Authors:
Jezequel, P
Joalland, MP
Milano, G
Lanoe, D
Ricolleau, G
Marie-Christine, E
Deporte-Fety, R
Citation: P. Jezequel et al., Common DPYD mutation associated with 5-fluorouracil toxicity detected by PCR-mediated site-directed mutagenesis, CLIN CHEM, 46(2), 2000, pp. 309-310
Authors:
Fumoleau, P
Deporte-Fety, R
Kerbrat, P
Citation: P. Fumoleau et al., UFT plus oral calcium folinate/vinorelbine for advanced breast cancer, ONCOLOGY-NY, 13(7), 1999, pp. 86-90
Authors:
Milano, G
Etienne, MC
Pierrefite, V
Barberi-Heyob, M
Deporte-Fety, R
Renee, N
Citation: G. Milano et al., Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity, BR J CANC, 79(3-4), 1999, pp. 627-630
Risultati:
1-7
|